A Study in Healthy Japanese Men to Test How Different Doses of BI 1569912 Are Taken up by the Body and How Well They Are Tolerated
Clinical trial NCT04958252 · COMPLETED
Trial details
- NCT number
- NCT04958252
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-05
- Primary completion
- 2023-10-30
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.